Laura Prendergast
Stock Analyst at Stifel
(4.87)
# 112
Out of 5,182 analysts
18
Total ratings
52.94%
Success rate
85.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintains: Buy | $15 → $24 | $19.95 | +20.30% | 2 | Mar 9, 2026 | |
| OLMA Olema Pharmaceuticals | Initiates: Buy | $48 | $16.10 | +198.14% | 1 | Feb 11, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Initiates: Buy | $23 | $8.40 | +173.81% | 1 | Feb 11, 2026 | |
| RVMD Revolution Medicines | Maintains: Buy | $85 → $170 | $96.43 | +76.29% | 4 | Jan 22, 2026 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $12 | $4.59 | +161.44% | 1 | Dec 4, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $115 → $135 | $102.74 | +31.40% | 2 | Nov 17, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Buy | $8 | $2.56 | +212.50% | 2 | Oct 16, 2025 | |
| ERAS Erasca | Initiates: Buy | $4 | $17.01 | -76.48% | 2 | Oct 16, 2025 | |
| COGT Cogent Biosciences | Initiates: Hold | $16 | $36.37 | -56.01% | 1 | Oct 16, 2025 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $2.17 | +637.33% | 2 | Aug 14, 2024 |
Tango Therapeutics
Mar 9, 2026
Maintains: Buy
Price Target: $15 → $24
Current: $19.95
Upside: +20.30%
Olema Pharmaceuticals
Feb 11, 2026
Initiates: Buy
Price Target: $48
Current: $16.10
Upside: +198.14%
BridgeBio Oncology Therapeutics
Feb 11, 2026
Initiates: Buy
Price Target: $23
Current: $8.40
Upside: +173.81%
Revolution Medicines
Jan 22, 2026
Maintains: Buy
Price Target: $85 → $170
Current: $96.43
Upside: +76.29%
Foghorn Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $12
Current: $4.59
Upside: +161.44%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $115 → $135
Current: $102.74
Upside: +31.40%
Black Diamond Therapeutics
Oct 16, 2025
Reinstates: Buy
Price Target: $8
Current: $2.56
Upside: +212.50%
Erasca
Oct 16, 2025
Initiates: Buy
Price Target: $4
Current: $17.01
Upside: -76.48%
Cogent Biosciences
Oct 16, 2025
Initiates: Hold
Price Target: $16
Current: $36.37
Upside: -56.01%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.17
Upside: +637.33%